Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Different fatty acid metabolism effects of (−)-Epigallocatechin-3-Gallate and C75 in Adenocarcinoma lung cancer

  • Joana Relat1,
  • Adriana Blancafort2,
  • Glòria Oliveras2, 3,
  • Sílvia Cufí3,
  • Diego Haro1,
  • Pedro F Marrero1 and
  • Teresa Puig2Email author
Contributed equally
BMC Cancer201212:280

DOI: 10.1186/1471-2407-12-280

Received: 11 November 2011

Accepted: 2 July 2012

Published: 6 July 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
11 Nov 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
16 Feb 2012 Reviewed Reviewer Report - Yoichiro Moriya
21 Mar 2012 Reviewed Reviewer Report - William Coleman
30 Mar 2012 Author responded Author comments - Teresa Puig
Resubmission - Version 3
30 Mar 2012 Submitted Manuscript version 3
30 Mar 2012 Author responded Author comments - Teresa Puig
Resubmission - Version 4
30 Mar 2012 Submitted Manuscript version 4
11 Jun 2012 Reviewed Reviewer Report - Yoichiro Moriya
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
2 Jul 2012 Editorially accepted
6 Jul 2012 Article published 10.1186/1471-2407-12-280

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Biochemistry and Molecular Biology, School of Pharmacy and Institute of Biomedicine of the University of Barcelona (IBUB)
(2)
Molecular Oncology (NEOMA), School of Medicine, University of Girona and Girona Institute for Biomedical Research (IDIBGi)
(3)
Molecular Oncology, Catalan Institute of Oncology (ICO), Girona Institute for Biomedical Research (IDIBGi)

Advertisement